473 studies found for:    "Squamous cell carcinoma of the head and neck"
Show Display Options
Rank Status Study
21 Terminated Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: docetaxel+CDDP;   Drug: docetaxel+S-1
22 Unknown  Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Interventions: Drug: Bevacizumab;   Drug: erlotinib;   Drug: Sulindac
23 Recruiting Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Interventions: Other: RTX + CDDP/5-FU;   Other: NO INDUCTION CHT + ( RTX + CETUXIMAB);   Other: INDUCTION CHT + ( RTX + CDDP/5-FU);   Other: INDUCTION CHT + ( RTX +CETUXIMAB)
24 Not yet recruiting Reduced-Volume Hypofractionated, PET-directed Intensity Modulated Radiotherapy Concurrent With Weekly Cisplatin Chemotherapy for Squamous Cell Carcinoma of the Head and Neck
Condition: T1/2N0-2 Squamous Cell Carcinoma of the Head and Neck
Intervention: Radiation: Intensity Modulated Radiotherapy
25 Suspended A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Interventions: Drug: AT-101;   Drug: Docetaxel
26 Recruiting Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Cetuximab
27 Active, not recruiting Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: DCA (dichloroacetate);   Drug: Placebo
28 Recruiting Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Drug: Erlotinib;   Other: Placebo;   Drug: Carboplatin
29 Recruiting Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Nivolumab;   Drug: Cetuximab;   Drug: Methotrexate;   Drug: Docetaxel
30 Terminated
Has Results
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma (HNSCC)
Intervention: Drug: Lymphoseek
31 Recruiting Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Radiation: Stereotactic Body Radiation Therapy (SBRT)
32 Active, not recruiting IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Carcinoma
Interventions: Radiation: Accl. RT;   Radiation: Accl. radiotherapy + Nimorazole
33 Recruiting Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Carcinoma, Squamous Cell of Head and Neck
Interventions: Drug: VTX-2337;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: 5-fluorouracil;   Drug: Placebo
34 Not yet recruiting Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA
Condition: Head and Neck Squamous Cell Carcinoma (HNSCC)
Intervention: Biological: Semi-allogenic human fibroblast (MRC-5) transfected with DNA
35 Active, not recruiting Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Cetuximab;   Drug: Docetaxel;   Drug: Cisplatin;   Drug: Fluorouracil;   Radiation: Radiotherapy (RT);   Other: Chemotherapy
36 Completed
Has Results
A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: Cetuximab;   Drug: Cisplatin;   Drug: 5-Fluorouracil
37 Completed Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Conditions: Advanced Squamous Cell Carcinoma;   Squamous Cell Carcinoma of Head and Neck;   SSCHN
Interventions: Drug: Docetaxel;   Drug: Cisplatin;   Drug: 5-Fluorouracil
38 Not yet recruiting Window Trial 5-aza in HNSCC, T-tare
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: 5-Azacitadine
39 Recruiting Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: AFATINIB;   Drug: Placebo of AFATINIB
40 Completed Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Gefitinib;   Drug: methotrexate

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years